$RYZ

Ryerson (RYZ) Q1 2026 Earnings Transcript

Ryerson (RYZ) reported Q1 2026 revenue of $1.57 billion (+37.9%) with tons shipped up 31.2% and average selling price up 5.2%. Net income was $4.5 million ($0.10/share); adjusted net income $13.1 million ($0.30). Adjusted EBITDA ex-LIFO rose to $67.4 million. Q2 guidance: net income $20–$22 million and revenue $1.86–$1.93 billion.

Original reporting
Published Jun 1, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ryerson (RYZ) Q1 2026 Earnings Transcript — source image
Decision brief

The 30-second read

$RYZBullishHigh
01

Why it matters

The transcript emphasizes improving sequential same-store revenue, margin expansion ex-LIFO, and early procurement synergies, while also flagging leverage deterioration and higher-than-expected LIFO expense as near-term headwinds. Q2 guidance provides a concrete earnings/EBITDA framework for traders to reprice the stock around integration execution and commodity sensitivity.

02

Market read

Concrete Q2 guidance ranges plus leverage and LIFO expense details make this more than a recap; it’s a repricing catalyst for earnings expectations and risk assessment.

03

What to watch

Working-capital cash outflow ($179M) and leverage increase to 5.1x could constrain buyback pace and raise financing sensitivity even with EBITDA growth.

Relevance 9/10Novelty 8/10Timing: After-hours/earnings transcript context ahead of next trading session

Background

Ryerson’s Q1 2026 performance is presented alongside early integration progress from the Olympic Steel acquisition, with LIFO accounting and leverage highlighted as key drivers.

Company-level read

Ticker impact

$RYZBullishHigh confidence
Context

Ryerson reports Q1 results and provides Q2 2026 guidance, including EBITDA ex-LIFO targets and revenue outlook tied to Olympic Steel integration.

Expected impact

Moderate positive bias if investors focus on EBITDA growth and synergy run-rate; downside risk if leverage/LIFO drag dominates.

Evidence & confidence

The article includes specific, decision-relevant datapoints (Q2 guidance ranges, leverage jump to 5.1x, LIFO expense above expectations, and early synergy realization) that directly affect Ryerson’s earnings outlook and risk premium.

Market effects

Metal service center demand signals (ISM-corroborated order activity) and integration-driven margin/EBITDA narrative may influence sentiment across peers.

Primarily North American industrial/materials sentiment via manufacturing activity and OEM contract demand commentary.

Limited direct global linkage; commodity-driven LIFO expense highlights sensitivity to global metal price moves.

Counterpoint

Contract business remains 4%-5% behind, and LIFO expense overshot—synergy may not fully offset margin/risk concerns if commodity prices stay elevated.

Key entities

  • Ryerson Holding Corporation

    Reports Q1 results, integration progress with Olympic Steel, and issues Q2 2026 guidance including adjusted EBITDA ex-LIFO and revenue ranges.

  • Olympic Steel

    Contributes to Ryerson’s consolidated results and synergy targets; its full-period inclusion drives the Q2 outlook.

  • Edward Lehner

    CEO who frames demand/order activity and integration progress during the earnings call.

Related articles

$RYZMedAI 8/10

Ryerson Reports Second Quarter 2026 Results

Ryerson Holding (NYSE:RYZ) reported Q2 2026 results ended June 30, its first full quarter after the Feb 13, 2026 Olympic Steel merger. Revenue was $2.01B, net income $15.5M or $0.30/share, and Adjusted EBITDA ex-LIFO $101.0M. It expects $13-$14M Q3 synergies and $52-$56M annualized run-rate.

$RYZMed

Ryerson Reports Second Quarter 2026 Results

Ryerson Holding Corp (RYZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ryerson Reports Second Quarter 2026 Results Exceeded top line guidance, improved profitability, and grew book value of equity while delivering targeted second-quarter synergies and building momentum toward exceeding our first-year synergy run-rate target CHICAGO – Ju

$CBKMMed

CONSUMERS BANCORP INC /OH/ (CBKM): Results of Operations and Financial Condition

CONSUMERS BANCORP INC /OH/ (CBKM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Consumers Bancorp, Inc. Reports: ● Net income increased by $404 thousand, or 15.3%, to $3.0 million for the three-month period ended September 30, 2026 compared with the same period last year. ● Net interest income increased by $1.2 million, or 12.9%, for the three-m

$GRABHighAI 8/10

Grab (GRAB) Earned $235M, but One Gain Drove the Jump

Grab (NASDAQ:GRAB) reported a Q2 2026 profit of $235M, up from $20M a year earlier, largely due to a $307M one-time gain. Core revenue grew 22% to $997M, with Financial Services up 59%. The company plans a $1.49B investment in Atome Financial, aiming for $6B in Financial Services by 2028. Grab generated $450M in adjusted free cash flow over the past year.

$RDDTMedAI 8/10

Forget User Growth: Here’s the Real Reason Reddit’s Revenue Is Exploding

Reddit (RDDT) expects Q3 revenue of $860M-$870M, following 61% YoY growth in Q2. US daily active users rose 6% to 53.2M, but US revenue grew 56%, indicating higher ad spending per user. Average US revenue per user reached $11.85, up 51% YoY. Operating margin is 28.25% over the past 12 months. CEO Steve Huffman noted volatility in search referrals but improved user retention.

$DHRHighAI 8/10

Danaher Q3 Earnings Call Highlights

Danaher (DHR) reported Q3 earnings, highlighting 5% biotech revenue growth and 4.5% life sciences growth. Diagnostics grew 7% ex-respiratory. The company raised its 2026 EPS guidance to $8.57-$8.62. Danaher expects 4-5% core revenue growth in Q4, excluding respiratory. It emphasized AI opportunities and strategic acquisitions like Masimo.